In this episode, I’ll discuss the dosing of lipid rescue therapy for LAST vs enteral drug toxicity. Subscribe on iTunes, Android, or Stitcher Intravenous lipid emulsion (ILE) or “lipid rescue” therapy is used in local anesthetic systemic toxicity (LAST) and enteral drug toxicity. Anesthesia, toxicology, and ACLS guidelines recommend intravenous fat emulsion with various levels of evidence. Ever […]
A free twice-weekly podcast where you can listen to critical care and hospital pharmacy information
Subscribe to the #1 ranked critical care and hospital pharmacy podcast, The Elective Rotation here:
Episode 1138: MRSA Nasal Swabs Work, But Only if You Use them…
In this episode, I’ll discuss an article on using MRSA nasal swab testing to optimize pneumonia treatment with empiric vancomycin. Subscribe on iTunes, Android, or Stitcher Many patients who are critically ill with community-acquired pneumonia are given vancomycin due to concern for MRSA as a causative pathogen. MRSA polymerase chain reaction (PCR) nasal swab testing […]
Episode 1137: More critical medications are going to be pushed into the prehospital setting
In this episode, I’ll discuss using a heparin bolus in the prehospital setting for patients with STEMI. Subscribe on iTunes, Android, or Stitcher Back in episode 1124, I discussed a study on the use of peripheral vasopressors in the prehospital setting that found they were feasible and safe with no peripheral tissue damage. While the […]
Episode 1136: Why does ketamine occassionally cause post-induction hemodynamic collapse?
In this episode, I’ll discuss why ketamine can sometimes cause post-induction hemodynamic instability when it is used for rapid sequence intubation. Subscribe on iTunes, Android, or Stitcher While ketamine is often considered a hemodynamically neutral induction agent for rapid sequence intubation, there are reports of post-induction hypotension and hemodynamic collapse occurring occasionally with ketamine use. […]
Episode 1135: Norepinephrine vs phenylephrine in traumatic brain injury – which is best?
In this episode, I’ll discuss an article about which vasopressor is best in early traumatic brain injury patients. Subscribe on iTunes, Android, or Stitcher Patients who have severe traumatic brain injury and develop hypotension that requires vasopressor therapy are already at risk for mortality and poor long term outcomes. But could the choice of vasopressor […]
Episode 1134: IVP Cefepime Pharmacokinetics in Critically Ill Patients With Sepsis Are Highly Variable
In this episode, I’ll discuss an article about the pharmacokinetic and pharmacodynamic properties of IV push cefepime in critically ill patients with sepsis. Subscribe on iTunes, Android, or Stitcher IV push cefepime has become a desirable method of administration, but data on the pharmacokinetic and pharmacodynamic properties of this administration technique in critically ill patients […]
Episode 1133: Can fondaparinux be useful in critically ill patients with severe renal dysfunction?
In this episode, I’ll discuss an article about using fondaparinux in critically ill patients with severe renal dysfunction. Subscribe on iTunes, Android, or Stitcher Evaluating options for venous thromboembolism (VTE) prophylaxis in critically ill patients is challenging and many issues can limit options including renal failure, bleeding risk, and thrombocytopenia. Fondaparinux use is often […]
Episode 1132: Beware ketamine infusions in your transplant patients
In this episode, I’ll discuss a case report of the effects of ketamine on the clearance of tacrolimus and sirolimus. Subscribe on iTunes, Android, or Stitcher Beyond ex vivo models showing that ketamine induces the clearance of CYP450 substrates, little is known about its effects in patients. A group of authors present in Pharmacotherapy a […]
Episode 1131: Effects of obesity on SC and IM medication administration
In this episode, I’ll discuss how obesity affects SC and IM medication administration. Subscribe on iTunes, Android, or Stitcher The thickness of the subcutaneous layer increases with obesity and this has potential implications for both subcutaneous and intramuscular medication administration. The AJHP recently published a review article on the implications of obesity for drug administration […]
Episode 1130: A study that proves what we’ve always felt about adenosine 6 vs 12mg for SVT
In this episode, I’ll discuss the use of an initial 6 mg vs 12 mg dose of adenosine for supraventricular tachycardia. Subscribe on iTunes, Android, or Stitcher One of my least favorite recommendations to give “by the book” is what dose of adenosine to use to terminate supraventricular tachycardia. While 6 mg is the recommended […]
Episode 1129: Do we need to worry about torsades from low-dose ondansetron in peri-operative patients?
In this episode, I’ll discuss the incidence of torsades from low-dose ondansetron in perioperative patients. Subscribe on iTunes, Android, or Stitcher Ondansetron prescribing information has a warning that Electrocardiogram (ECG) changes including QT interval prolongation have been seen in patients receiving ondansetron. Some references list this as a concern, but many clinicians believe that a […]
Episode 1127: Oxacillin seems safer than nafcillin (retrospective data)
In this episode, I’ll discuss an article about the incidence of acute kidney injury with the use of nafcillin versus oxacillin. Subscribe on iTunes, Android, or Stitcher Nafcillin and oxacillin are both antistaphylococcal penicillins used for the treatment of MSSA infections. Efficacy, cost, spectrum of activity, and pharmacokinetics are all similar between these two antibiotics. […]
- 1
- 2
- 3
- …
- 95
- Next Page »
